2025-01-17 03:51:02
Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Study of LNK01001 in Patients with Ankylosing Spondylitis
Health/ 2023-07-22
Lynk Pharmaceuticals Announces First Pat...

HANGZHOU,China,Jan. 19,2022-- Lynk Pharmaceuticals Co.,Ltd. (hereinafter referred to as \'Lynk Pharmaceuticals\'),an innovative clinical sta...

Transplant Connect to Expand Human Biologics Management Software with Investment from InVita Healthcare Technologies
Health/ 2023-07-22
Transplant Connect to Expand Human Biolo...

LOS ANGELES,Jan. 19,2022-- Transplant Connect,the world\'s leading software provider for the donation and transplantation field,is pleased t...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release